Only one clinical factor affected adherence: the patient’s cancer stage. Those women whose breast cancer was in an earlier stage were more likely to provide specimens. Those who had higher functional well-being and lower ratings of religiosity also were more adherent to the study. The women who were satisfied with their care in terms of access and communication with their oncologist were more likely to return a biospecimen. But, the most significant predictor of a survivor’s participation was satisfaction with the amount of time her oncologist spent with her.
Based on their research, the authors suggest that greater provider-patient communication and interaction would lead to improved recruitment for clinical trials.
Sheppard VB, Hurtado-de-Mendoza A, Zheng YL, et al. Biospecimen donation among black and white breast cancer survivors: opportunities to promote precision medicine [published online November 16, 2017]. J Cancer Surviv. doi: 10.1007/s11764-017-0646-8